Autoantibody biomarkers identified and validated using Sengenics protein arrays have shown utility in a range of high-value applications—from early disease detection and patient stratification to treatment monitoring and prediction of treatment outcomes and immune-related adverse events (irAE).

Learn more about key applications for Sengenics technology and services.

Biomarker Discovery and Validation

Identification of autoantibody biomarker

Patient Stratification

Intra-disease stratification, identification of cohorts and clinical trial patient enrichment.